v3.26.1
Divestitures - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 13, 2026
Jun. 30, 2026
Jun. 27, 2025
Jun. 30, 2026
Jun. 27, 2025
Disposal Group, Held-for-Sale, Not Discontinued Operations | Percocet and Endocet Businesses          
Disposal Group, Including Discontinued Operations [Line Items]          
Divestiture consideration $ 25.0        
Contingent consideration arrangement, term 5 years        
Projected future cash flows and a discount rate 16.00%        
Disposal groupincluding discontinued operation, estimated fair value $ 177.1        
Disposal group including discontinued operation, carrying amount 359.0        
Non-cash impairment charge $ 181.9        
Transition services agreement, term 3 months        
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Par Health          
Disposal Group, Including Discontinued Operations [Line Items]          
Discontinued operation, amount of continuing cash flows after disposal   $ 2.6   $ 5.7  
Provisions certain agreements, income   1.2   1.2  
Provisions certain agreements, owed   $ 10.5   $ 10.5  
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Therakos Divestiture          
Disposal Group, Including Discontinued Operations [Line Items]          
Transition services agreement, term   18 months   18 months  
Payments for divestiture         $ 6.2
Transition services agreement, revenue   $ 0.2 $ 2.2 $ 0.6 $ 5.2